Tag: competition

WINSTON-SALEM, N.C., July 01, 2025 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney” or the “Company"), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease (CKD), today announced the completion of the domestication process to change the jurisdiction of incorporation of the Company from the Cayman Islands to Delaware. The domestication was approved by shareholders of the Company at its Annual General Meeting held on May 29, 2025. Effective as of July 1, 2025, each (i) Class A ordinary share automatically converted into one share of Class A common stock of ProKidney Corp., a Delaware corporation and (ii) each Class B ordinary share automatically converted into one share of Class B common stock of ProKidney. ProKidney common stock will begin trading on July 2, 2025, and the Company's trading symbol on the Nasdaq Stock Market will remain unchanged as "PROK." The Company’s CUSIP number relating to its Class A common stock changed to 74291D 104. The Company does not anticipate any impact to day-to-day business operations as a result of the domestication.

 The Star-Studded Kickoff Event Hosted by Nick Cannon and Jermaine Dupri featured a Performance by Social Media Pioneer Soulja Boy

New Alliance Aims to Scale Grocery Logistics for SMEs With Real-Time Tracking, IoT Integration, and Regional Economic Impact

The Asia-Pacific Milk Powder Market is poised to grow from US$ 11.54 billion in 2024 to US$ 18.25 billion by 2033, registering a CAGR of 5.22% from 2025 to 2033. Key drivers include increased urbanization, longer shelf life, higher infant numbers, and rising demand for convenient dairy alternatives. The market is buoyed by growing health consciousness and increasing disposable income, particularly in China and India. E-commerce and modern retail expansion enhance accessibility. However, challenges like fluctuating raw material prices and intense competition persist. Key players include Nestle, Fonterra, and Amul.